EUVIMEDEUVIMED entdecken
Open Access · CC BY 2.0

Up-regulation of SLC7A11/xCT creates a vulnerability to selenocystine-induced cytotoxicity

Shawn Lu Wen Tan iD, Hui Min Tan, Erez Israeli, Indah Fatihah, Vignesh Ramachandran, Shamsia Bte Ali, Shane Jun An Goh, Jillian Wee, Alicia Qian Ler Tan, Wai Leong Tam, Weiping Han

Biochemical Journal · 20.12.2023 · 480 (24) · 2045-2058

DOI: 10.1042/bcj20230317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Journal, online erschienen am 18.12.2023. Verfasst von Shawn Lu Wen Tan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, Proteos, Singapore 138673, R…. Hauptthemen laut MEDLINE: Cystine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: MOH | National Medical Research Council, A*STAR | Institute of Molecular and Cell Biology, National Research Foundation Singapore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The SLC7A11/xCT cystine and glutamate antiporter has emerged as an attractive target for cancer therapy due to its selective overexpression in multiple cancers and its role in preventing ferroptosis. Utilizing pharmacological and genetic approaches in hepatocellular carcinoma cell lines, we demonstrate that overexpression of SLC7A11 engenders hypersensitivity towards l-selenocystine, a naturally occurring diselenide that bears close structural similarity to l-cystine. We find that the abundance of SLC7A11 positively correlates with sensitivity to l-selenocystine, but surprisingly, not to Erastin, an inhibitor of SLC7A11 activity. Our data indicate that SLC7A11 acts as a transport channel for l-selenocystine, which preferentially incites acute oxidative stress and damage eventuating to cell death in cells that highly express SLC7A11. Hence, our findings raise the prospect of l-selenocystine administration as a novel strategy for targeting cancers that up-regulate SLC7A11 expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CystineCell Line, TumorUp-RegulationAmino Acid Transport System y+Organoselenium Compounds

Stichwörter der Autor:innen

SLC7A11cancer therapeutichepatocellular carcinomareactive oxygen speciesselenocystine

Substanzen

CystineAmino Acid Transport System y+selenocystineOrganoselenium Compounds

Autor:innen und Institutionen

  • Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Republic of Singapore.
  • Institute of Biochemistry, Food Science and Nutrition, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot, Israel.
  • NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, 14 Medical Drive, Singapore 117599, Republic of Singapore.
  • Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, 8 Medical Drive, Singapore 117597, Republic of Singapore.
  • Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), 60 Biopolis Drive, Genome, Singapore 138672, Republic of Singapore.
  • Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore 117599, Republic of Singapore.

ORCID-Profile: Shawn Lu Wen Tan

Förderung

  • MOH | National Medical Research Council
  • A*STAR | Institute of Molecular and Cell Biology
  • National Research Foundation Singapore

Zitieren

APA

Tan, S. L. W., Tan, H. M., Israeli, E., Fatihah, I., Ramachandran, V., Ali, S. B., Goh, S. J. A., Wee, J., Tan, A. Q. L., Tam, W. L., & Han, W. (2023). Up-regulation of SLC7A11/xCT creates a vulnerability to selenocystine-induced cytotoxicity. Biochemical Journal, 480(24), 2045-2058. https://doi.org/10.1042/bcj20230317

Vancouver

Tan SLW, Tan HM, Israeli E, Fatihah I, Ramachandran V, Ali SB, et al. Up-regulation of SLC7A11/xCT creates a vulnerability to selenocystine-induced cytotoxicity. Biochemical Journal. 2023;480(24):2045-2058. doi:10.1042/bcj20230317

BibTeX
@article{Tan2023,
  author = {Tan, Shawn Lu Wen and Tan, Hui Min and Israeli, Erez and Fatihah, Indah and Ramachandran, Vignesh and Ali, Shamsia Bte and Goh, Shane Jun An and Wee, Jillian and Tan, Alicia Qian Ler and Tam, Wai Leong and Han, Weiping},
  title = {Up-regulation of SLC7A11/xCT creates a vulnerability to selenocystine-induced cytotoxicity},
  journal = {Biochemical Journal},
  year = {2023},
  volume = {480},
  number = {24},
  pages = {2045--2058},
  doi = {10.1042/bcj20230317}
}
Kostenlos starten →